|ENVISION HEALTHCARE CORP filed this Form 8-K on 12/06/2017|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 6, 2017 (December 1, 2017)
ENVISION HEALTHCARE CORPORATION
(Exact Name of Registrant as Specified in its Charter)
(Registrant’s Telephone Number, Including Area Code)
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company [ ]
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
On December 1, 2017, the Board of Directors (the “Board”) of Envision Healthcare Corporation, a Delaware corporation (the “Company”) unanimously appointed William A. Sanger to serve as non-executive Chairman of the Board for a term expiring December 1, 2019, as contemplated by the Company’s Second Amended and Restated By-laws. Mr. Sanger previously served as the Company’s Executive Chairman. Following Mr. Sanger’s appointment as non-executive Chairman, the Company no longer has an Executive Chairman. Mr. Sanger will no longer receive the executive compensation that was previously payable under his employment agreement with the Company. In addition to the Company’s standard board compensation payable to non-employee directors, Mr. Sanger will receive an annual retainer of $150,000 for serving as the Board’s non-executive Chairman.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: December 6, 2017